Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tracks Real-World lung cancer care for seniors

NCT ID NCT06646471

Knowledge-focused Sponsor: GFPC Investigation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how adults aged 70 and older with non-small cell lung cancer are treated in everyday medical practice. Researchers will track 500 participants to understand which treatments work best, how safe they are, and how they affect quality of life. The goal is to gather real-world data to help guide better care for older patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient ≥70 years * Non-small-cell lung cancer for which the multidisciplinary consultation required systemic treatment regardless of Tumor-Node-Metastasis (TNM) stage * Patient naïve to systemic anticancer treatment for bronchial neoplasia * Patient covered by social security * Patient eligible for systemic treatment * Systemic treatment with marketing authorization in the indication, available in routine care early access or compassionate access. * Patient able to understand the protocol * Patient not opposed to the collection of data concerning him/her * Signature of study consent form. Exclusion Criteria: * Patients under guardians or curators * Patient not under the care of the investigating center and not monitored by the investigating center * Patient already treated with systemic therapy for NSCLC

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer Non-small cell lung cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    41 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Annecy Genevois

    RECRUITING

    Pringy, 74374, France

  • CH Bastia

    NOT_YET_RECRUITING

    Bastia, 20600, France

  • CH Elbeuf

    RECRUITING

    Elbeuf, 76503, France

  • CH La Rochelle

    RECRUITING

    La Rochelle, 17000, France

  • CH Métropole-Savoie

    RECRUITING

    Chambéry, 73000, France

  • CH du Pays d Aix

    RECRUITING

    Aix-en-Provence, 13616, France

  • CHD Les Oudairies

    RECRUITING

    La Roche-sur-Yon, 85000, France

  • CHITS Toulon Sainte Musse

    RECRUITING

    Toulon, 83056, France

  • CHU Dupuytren

    RECRUITING

    Limoges, 87042, France

  • CHU Hôpital Montpied

    NOT_YET_RECRUITING

    Clermont-Ferrand, 63000, France

  • CHU Hôpital Ponchailloux

    RECRUITING

    Rennes, 35033, France

  • CHU de la Réunion

    RECRUITING

    Saint-Pierre, 97410, France

  • CLCC Paul Strauss

    RECRUITING

    Strasbourg, 67000, France

  • Cantre Catalan d Oncologie

    NOT_YET_RECRUITING

    Perpignan, 66000, France

  • Centre Hospitalier du Cotentin

    RECRUITING

    Cherbourg, 50102, France

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69373, France

  • Centre d Oncologie de Gentilly

    RECRUITING

    Nancy, 54000, France

  • Clinique Mutualiste

    RECRUITING

    Saint-Nazaire, 44600, France

  • GHEF Site de Meaux

    RECRUITING

    Meaux, 77100, France

  • Hôpital A. Mignot

    RECRUITING

    Le Chesnay, 78157, France

  • Hôpital Européen de Marseille

    RECRUITING

    Marseille, 13003, France

  • Hôpital Henri Duffaut

    RECRUITING

    Avignon, 84000, France

  • Hôpital Nord OUest

    RECRUITING

    Villefranche-sur-Saône, 69655, France

  • Hôpital Robert Boulin

    RECRUITING

    Libourne, 33505, France

  • Hôpital d'Instruction des Armées Saint-Anne

    RECRUITING

    Toulon, 83041, France

  • Hôpital de la Vallée - Service Pneumologie

    RECRUITING

    Longjumeau, 91160, France

  • Institut du Cancer d'Avignon

    RECRUITING

    Avignon, 84918, France

  • Oncologie CHBA

    RECRUITING

    Vannes, 56000, France

  • Oncologie Thoracique Hôpital Morvan

    RECRUITING

    Brest, 29200, France

  • Oncologie Thoracique Hôpital Nord

    RECRUITING

    Marseille, 13915, France

  • Pneumologie CHI Creteil

    RECRUITING

    Créteil, 94010, France

  • Pneumologie CHI Quimper

    RECRUITING

    Quimper, 29000, France

  • Pneumologie CHR

    RECRUITING

    Orléans, 45067, France

  • Pneumologie CHU Felix Guyon

    RECRUITING

    Saint-Denis, 97400, France

  • Pneumologie CHU St Etienne

    RECRUITING

    Saint-Etienne, 42270, France

  • Pneumologie Centre François Baclesse

    NOT_YET_RECRUITING

    Caen, 14000, France

  • Pneumologie Hospices Civils de Colmar

    RECRUITING

    Colmar, 68024, France

  • Pneumologie Hôpital Charles Nicolle

    NOT_YET_RECRUITING

    Rouen, 76031, France

  • Pneumologie Hôpital Cochin

    NOT_YET_RECRUITING

    Paris, 75014, France

  • Pneumologie Hôpital Tenon

    NOT_YET_RECRUITING

    Paris, 75970, France

  • Polyclinique de Blois

    NOT_YET_RECRUITING

    La Chaussée-Saint-Victor, 41260, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.